Maria Vargas1,2, Yuda Sutherasan3, Iole Brunetti4, Camilla Micalizzi4, Angelo Insorsi4, Lorenzo Ball4, Marta Folentino4, Rosanna Sileo4, Arduino De Lucia4, Manuela Cerana4, Alessandro Accattatis4, Domenico De Lisi4, Angelo Gratarola5, Francesco Mora6, Giorgio Peretti6, Giuseppe Servillo7, Paolo Pelosi4. 1. Department of Surgical Sciences and Integrated Diagnostics, San Martino Policlinic Hospital, IRCCS for Oncology, University of Genoa, Genoa, Italy - vargas.maria82@gmail.com. 2. Department of Neurosciences, Reproductive and Odonthostomatologic Sciences, "Federico II" University, Naples, Italy - vargas.maria82@gmail.com. 3. Division of Pulmonary and Critical Care Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. 4. Department of Surgical Sciences and Integrated Diagnostics, San Martino Policlinic Hospital, IRCCS for Oncology, University of Genoa, Genoa, Italy. 5. Division of Anesthesia and Intensive Care, San Martino Policlinic Hospital, IRCCS for Oncology, Genoa, Italy. 6. Department of Otorhinolaryngology, Head and Neck Surgery, San Martino Policlinic Hospital, IRCCS for Oncology, University of Genoa, Genoa, Italy. 7. Department of Neurosciences, Reproductive and Odonthostomatologic Sciences, "Federico II" University, Naples, Italy.
Abstract
BACKGROUND: Quality of life and mortality after percutaneous dilatational tracheotomy (PDT) has been poorly investigated. The aims of this study were to evaluate the independent risk factors for Intensive Care Unit (ICU) mortality and investigate quality of life over the first year after PDT in critically ill patients. METHODS: This was a prospective, single-center, cohort study performed in a tertiary care University Hospital, enrolling consecutive ICU patients requiring elective PDT, collecting data during the tracheotomy procedure and the ICU stay. Follow-up was performed at three, six and twelve months after PDT. The medical interview included the Euro Quality of Life questionnaire comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). RESULTS: A total of 137 patients were included in the study. In the multivariate analysis, ICU mortality was independently associated with age (OR 1.089; P=0.003) and SAPS II (OR 1.047; P=0.003), and inversely with neurologic disease (OR 0.162; P=0.004). Mortality increased over time (ICU mortality 26.7%; in-hospital mortality 43.1%; 3-months mortality 47.4%; 6-months mortality 61.3%; and 1-year mortality 70.8%; P=0.0001). Tracheostomized patients due to respiratory disease had a higher ICU mortality (50%) compared to those with neurological disease (13.6%). quality of life (QoL) of tracheostomized patients was severely compromised at 3-months (QoL: 17, 15-19), 6-months (QoL: 17; 16-19), while moderately compromised at 1-year (QoL: 13; 9-16). A subgroup analysis showed better QoL at 3-months, 6-months and 1-year in respiratory compared to neurological tracheostomized patients (P=0.01). CONCLUSIONS: Patients baseline characteristics and indication for PDT procedure are important determinants of in-ICU mortality and QoL in tracheostomized patients.
BACKGROUND: Quality of life and mortality after percutaneous dilatational tracheotomy (PDT) has been poorly investigated. The aims of this study were to evaluate the independent risk factors for Intensive Care Unit (ICU) mortality and investigate quality of life over the first year after PDT in critically illpatients. METHODS: This was a prospective, single-center, cohort study performed in a tertiary care University Hospital, enrolling consecutive ICU patients requiring elective PDT, collecting data during the tracheotomy procedure and the ICU stay. Follow-up was performed at three, six and twelve months after PDT. The medical interview included the Euro Quality of Life questionnaire comprising five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). RESULTS: A total of 137 patients were included in the study. In the multivariate analysis, ICU mortality was independently associated with age (OR 1.089; P=0.003) and SAPS II (OR 1.047; P=0.003), and inversely with neurologic disease (OR 0.162; P=0.004). Mortality increased over time (ICU mortality 26.7%; in-hospital mortality 43.1%; 3-months mortality 47.4%; 6-months mortality 61.3%; and 1-year mortality 70.8%; P=0.0001). Tracheostomized patients due to respiratory disease had a higher ICU mortality (50%) compared to those with neurological disease (13.6%). quality of life (QoL) of tracheostomized patients was severely compromised at 3-months (QoL: 17, 15-19), 6-months (QoL: 17; 16-19), while moderately compromised at 1-year (QoL: 13; 9-16). A subgroup analysis showed better QoL at 3-months, 6-months and 1-year in respiratory compared to neurological tracheostomizedpatients (P=0.01). CONCLUSIONS:Patients baseline characteristics and indication for PDT procedure are important determinants of in-ICU mortality and QoL in tracheostomized patients.
Authors: Brendan A McGrath; Michael J Brenner; Stephen J Warrillow; Vinciya Pandian; Asit Arora; Tanis S Cameron; José Manuel Añon; Gonzalo Hernández Martínez; Robert D Truog; Susan D Block; Grace C Y Lui; Christine McDonald; Christopher H Rassekh; Joshua Atkins; Li Qiang; Sébastien Vergez; Pavel Dulguerov; Johannes Zenk; Massimo Antonelli; Paolo Pelosi; Brian K Walsh; Erin Ward; You Shang; Stefano Gasparini; Abele Donati; Mervyn Singer; Peter J M Openshaw; Neil Tolley; Howard Markel; David J Feller-Kopman Journal: Lancet Respir Med Date: 2020-05-15 Impact factor: 30.700
Authors: Rajesh K Pande; Ashish Bhalla; Sheila N Myatra; Lakshmi N Yaddanpuddi; Sachin Gupta; Tapas K Sahoo; Ravi Prakash; Tarun A Sahu; Akansha Jain; Palepu Bn Gopal; Dhruva Chaudhry; Deepak Govil; Shubhal Dixit; Srinivas Samavedam Journal: Indian J Crit Care Med Date: 2020-11
Authors: Sangeeta Mehta; Anita Brondani; George Tomlinson; Leslie Chu; Stacey Burns; Andrea Matte; Jill I Cameron; Jan O Friedrich; Jill Rudkowski; Priscila Robles; Yoanna Skrobik; Margaret Herridge; Neill K J Adhikari Journal: Crit Care Explor Date: 2022-10-07
Authors: B A McGrath; N Ashby; M Birchall; P Dean; C Doherty; K Ferguson; J Gimblett; M Grocott; T Jacob; C Kerawala; P Macnaughton; P Magennis; R Moonesinghe; P Twose; S Wallace; A Higgs Journal: Anaesthesia Date: 2020-06-05 Impact factor: 12.893